• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Antibody-drug conjugates: beyond current approvals and potential future strategies”.
    No. Publication Date Citing Article
    1 2023 Ritwik Maiti, Bhumika Patel, Nrupesh Patel, Mehul Patel, Alkesh Patel, Nirav Dhanesha. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities, Archives of Pharmacal Research. 2023; 46: 361.  https://doi.org/10.1007/s12272-023-01447-0
    2 2023 Rafael F. A. Gomes, Bruno M. F. Gonçalves, Késsia H. S. Andrade, Bárbara B. Sousa, Nuno Maulide, Gonçalo J. L. Bernardes, Carlos A. M. Afonso. Unlocking the Potential of Bio‐Based Nitrogen‐Rich Furanic Platforms as Biomass Synthons, Angewandte Chemie International Edition. 2023; 62: e202304449.  https://doi.org/10.1002/anie.202304449
    3 2023 Feng Wen, Tianhai Lin, Peng Zhang, Yali Shen. 2023;   https://doi.org/10.21203/rs.3.rs-2424409/v1
    4 2022 Erin F. Cobain, Daniel F. Hayes. Expanding the reach of HER2-targeted therapies: transformation of an historical paradigm, Journal of Clinical Investigation. 2022; 132: e166384.  https://doi.org/10.1172/JCI166384
    5 2023 Christian Werner Wichmann, Ingrid Julienne Georgette Burvenich, Nancy Guo, Angela Rigopoulos, Alexander McDonald, Diana Cao, Graeme Joseph O'Keefe, Sylvia Jie Gong, Hui Kong Gan, Fiona Elizabeth Scott, Nabendu Pore, Steven Coats, Andrew Mark Scott. Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2, Nuclear Medicine and Biology. 2023; 122-123: 108366108366.  https://doi.org/10.1016/j.nucmedbio.2023.108366
    6 2022 Marilia Barreca, Noémie Lang, Chiara Tarantelli, Filippo Spriano, Paola Barraja, Francesco Bertoni. Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences, Exploration of Targeted Anti-tumor Therapy. 2022; 763.  https://doi.org/10.37349/etat.2022.00112
    7 2023 Rafael F. A. Gomes, Bruno M. F. Gonçalves, Késsia H. S. Andrade, Bárbara B. Sousa, Nuno Maulide, Gonçalo J. L. Bernardes, Carlos A. M. Afonso. Unlocking the Potential of Bio‐Based Nitrogen‐Rich Furanic Platforms as Biomass Synthons, Angewandte Chemie. 2023; 135: e202304449.  https://doi.org/10.1002/ange.202304449